As of July 1, 2024, there are 105 Ozempic, Wegovy, and Rybelsus gastroparesis cases pending in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
Its the same as with semaglutide, except tirzepatides superior dual-agonist efficacy seems to correspond to a higher side effect risk
Advanced Body and Laser Center is a trusted provider of non-surgical weight loss treatments in the San Joaquin Valley
The publisher is not affiliated with the manufacturers of any FDA-approved branded GLP-1 medication referenced for comparison purposes (including Wegovy, Ozempic, Mounjaro, and Zepbound, which are trademarks of their respective owners)
Women considering probiotics should discuss this with their healthcare provider to ensure appropriateness for their individual circumstances